{"bill": {"#text": "\n\t", "form": {"current-chamber": {"#tail": "\n\t\t", "#text": "IN THE HOUSE OF REPRESENTATIVES"}, "#text": "\n\t\t", "congress": {"#tail": "\n\t\t", "#text": "113th CONGRESS"}, "#tail": "\n\t", "legis-num": {"#tail": "\n\t\t", "#text": "H. R. 4771"}, "official-title": {"#tail": "\n\t", "#text": "To amend the Controlled Substances Act to more effectively regulate anabolic steroids."}, "session": {"#tail": "\n\t\t", "#text": "2d Session"}, "distribution-code": {"#tail": "\n\t\t", "@display": "yes", "#text": "I"}, "action": {"action-date": {"#tail": "\n\t\t\t", "@date": "20140529", "#text": "May 29, 2014"}, "#tail": "\n\t\t", "action-desc": {"#tail": "\n\t\t", "#text": "\n        ", "committee-name": [{"#tail": ", and in addition to the Committee on the ", "@committee-id": "HIF00", "#text": "Committee on Energy and Commerce"}, {"#tail": ", for a period to be subsequently determined by the Speaker, in each case for consideration of such\n\t\t\t provisions as fall within the jurisdiction of the committee concerned", "@committee-id": "HJU00", "#text": "Judiciary"}], "sponsor": {"#tail": " (for himself and ", "#text": "Mr. Pitts", "@name-id": "P000373"}, "cosponsor": {"#tail": ") introduced the following bill; which was referred to the ", "#text": "Mr. Pallone", "@name-id": "P000034"}}, "#text": "\n\t\t\t"}, "legis-type": {"#tail": "\n\t\t", "#text": "A BILL"}}, "@bill-stage": "Introduced-in-House", "@bill-type": "olc", "@dms-id": "H64262D40BC88475CB7B3772A22FF4AC9", "@public-private": "public", "legis-body": {"#tail": "\n", "@style": "OLC", "section": [{"@section-type": "section-one", "#tail": "\n    ", "text": {"#tail": "\n\t\t", "quote": {"short-title": {"#tail": "\n        ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "act", "#text": "Designer Anabolic Steroid Control Act of 2014", "@value": "Designer Anabolic Steroid Control Act of 2014", "@proposed": "true"}, "#text": "\n            "}, "#tail": ".", "#text": "\n          "}, "#text": "This Act may be cited as the ", "@display-inline": "no-display-inline"}, "enum": {"#tail": "\n      ", "#text": "1."}, "header": {"#tail": "\n      ", "#text": "Short title"}, "#text": "\n      ", "@id": "H56FEAAE8071F40898B411CC1F313C49D"}, {"#tail": "\n  ", "enum": {"#tail": "\n      ", "#text": "2."}, "header": {"#tail": "\n\t\t\t", "#text": "Amendments to the Controlled Substances Act"}, "subsection": [{"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended\u2014", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 102(41) of the Controlled Substances Act", "@value": "Controlled Substances Act/s:102/p:41"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 802(41)", "@value": "usc/21/802/41"}, "@parsable-cite": "usc/21/802", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(a)"}, "header": {"#tail": "\n        ", "#text": "Definitions"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\u2014", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Controlled Substances Act/s:102/p:41/sp:A"}, "#text": "in "}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "#text": "\n          ", "@id": "HFC658AFCD2CE423B8EE681D81D247392", "subparagraph": [{"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": ", by striking ", "@entity-type": "act", "#text": "clause (xlix)", "@value": "Controlled Substances Act/s:102/p:41/sp:A/cl:xlix"}, "#text": "in ", "quote": {"#tail": " at the end;", "#text": "and"}}, "enum": {"#tail": "\n            ", "#text": "(A)"}, "@id": "H8A161FDA6B344935921EED3CEABC307C", "#text": "\n            "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " as ", "@entity-type": "act", "#text": "clause (xlx)", "@value": "Controlled Substances Act/s:102/p:41/sp:A/cl:xlx"}, {"#tail": "; and", "@entity-type": "act", "#text": "clause (lxxvii)", "@value": "Controlled Substances Act/s:102/p:41/sp:A/cl:lxxvii", "@proposed": "true"}], "#text": "by redesignating "}, "enum": {"#tail": "\n            ", "#text": "(B)"}, "@id": "H31579D98130848548555A7D100B73887", "#text": "\n            "}, {"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " the following:", "@entity-type": "act", "#text": "clause (xlix)", "@value": "Controlled Substances Act/s:102/p:41/sp:A/cl:xlix"}, "#text": "by inserting after "}, "enum": {"#tail": "\n            ", "#text": "(C)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n            ", "#text": "; and"}, "#tail": "\n\t\t\t\t\t", "clause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "5\u03b1-Androstan-3,6,17-trione;"}, "enum": {"#tail": "\n                ", "#text": "(l)"}, "@id": "H11883B03A32449EA8401E924CD91D4B6", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Androst-4-ene-3,6,17-trione;"}, "enum": {"#tail": "\n                ", "#text": "(li)"}, "@id": "HE175C858300C4329AE5B5F7DDDE0411B", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Androsta-1,4,6-triene-3,17-dione;"}, "enum": {"#tail": "\n                ", "#text": "(lii)"}, "@id": "H0A1E6E4268CC454B9367FEF795D0CC19", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "6-bromo-androstan-3,17-dione;"}, "enum": {"#tail": "\n                ", "#text": "(liii)"}, "@id": "H71FA551CF7974220A964F137BAD5CA6D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "6-bromo-androsta-1,4-diene-3,17-dione;"}, "enum": {"#tail": "\n                ", "#text": "(liv)"}, "@id": "HD71A5A20DAAF4A858D7C1077466BD320", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;"}, "enum": {"#tail": "\n                ", "#text": "(lv)"}, "@id": "H55F04B47619B4AA18D62BB6282F33496", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "4-chloro-17\u03b1-methyl-androst-4-ene-3\u03b2,17\u03b2-diol;"}, "enum": {"#tail": "\n                ", "#text": "(lvi)"}, "@id": "HA9E1D88155EB4B1F9CBA5F2EF9BDE56E", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-en-3-one;"}, "enum": {"#tail": "\n                ", "#text": "(lvii)"}, "@id": "HBFCC6D84CEE9471D986EC99406A6F4E4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "4-chloro-17\u03b1-methyl-17\u03b2-hydroxy-androst-4-ene-3,11-dione;"}, "enum": {"#tail": "\n                ", "#text": "(lviii)"}, "@id": "H80CAFB2E1F4A4C7AB5F5CE39A5EBB714", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "4-chloro-17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;"}, "enum": {"#tail": "\n                ", "#text": "(lix)"}, "@id": "H00EE1292A64341D3BB76F7FE0C9C2262", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b1-androstan-3-one;"}, "enum": {"#tail": "\n                ", "#text": "(lx)"}, "@id": "H4B6F46074DF548EF8167202CE32EF7B5", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "2\u03b1,17\u03b1-dimethyl-17\u03b2-hydroxy-5\u03b2-androstan-3-one;"}, "enum": {"#tail": "\n                ", "#text": "(lxi)"}, "@id": "HA2DEACBCB6224DFAB42CFFE6956C9FFC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "2\u03b1,3\u03b1-epithio-17\u03b1-methyl-5\u03b1-androstan-17\u03b2-ol;"}, "enum": {"#tail": "\n                ", "#text": "(lxii)"}, "@id": "H8B17F50FC5D84620879ED903D4728F35", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "[3,2-c]-furazan-5\u03b1-androstan-17\u03b2-ol;"}, "enum": {"#tail": "\n                ", "#text": "(lxiii)"}, "@id": "HC8898513A5D548D39731046BC2BAF440", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "3\u03b2-hydroxy-estra-4,9,11-trien-17-one;"}, "enum": {"#tail": "\n                ", "#text": "(lxiv)"}, "@id": "H01395EBFE2404867AC82B04A5E445BBC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "17\u03b1-methyl-androst-2-ene-3,17\u03b2-diol;"}, "enum": {"#tail": "\n                ", "#text": "(lxv)"}, "@id": "H47CA410C36C84E229A45EA767C2C6FF1", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "17\u03b1-methyl-androsta-1,4-diene-3,17\u03b2-diol;"}, "enum": {"#tail": "\n                ", "#text": "(lxvi)"}, "@id": "H8DB7B97063F843959967F7CAB0E1DE68", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Estra-4,9,11-triene-3,17-dione;"}, "enum": {"#tail": "\n                ", "#text": "(lxvii)"}, "@id": "H7EE2B80241974070B9C5B9812B105CA4", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "18a-Homo-3-hydroxy-estra-2,5(10)-dien-17-one;"}, "enum": {"#tail": "\n                ", "#text": "(lxviii)"}, "@id": "HD47C874AACB142E7814B0683037509EC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "6\u03b1-Methyl-androst-4-ene-3,17-dione;"}, "enum": {"#tail": "\n                ", "#text": "(lxix)"}, "@id": "H9941829EF22441B59DDBEEDE3705C77D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "17\u03b1-Methyl-androstan-3-hydroxyimine-17\u03b2-ol;"}, "enum": {"#tail": "\n                ", "#text": "(lxx)"}, "@id": "H702359E296CC41CB9BE5ED0DEE9EF8DC", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "17\u03b1-Methyl-5\u03b1-androstan-17\u03b2-ol;"}, "enum": {"#tail": "\n                ", "#text": "(lxxi)"}, "@id": "HDB3A34F40CC5431D859C637CB52E7D0D", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "17\u03b2-Hydroxy-androstano[2,3-d]isoxazole;"}, "enum": {"#tail": "\n                ", "#text": "(lxxii)"}, "@id": "H13EED1CF9387428E959B6ED6BA810D92", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "17\u03b2-Hydroxy-androstano[3,2-c]isoxazole;"}, "enum": {"#tail": "\n                ", "#text": "(lxxiii)"}, "@id": "H0BF54668F71E497E83E9212A4A82EE1F", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "4-Hydroxy-androst-4-ene-3,17-dione[3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol;"}, "enum": {"#tail": "\n                ", "#text": "(lxxiv)"}, "@id": "H1D9CB063AE494419BECA4FEA60AC56CF", "#text": "\n                "}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "[3,2-c]pyrazole-androst-4-en-17\u03b2-ol;"}, "enum": {"#tail": "\n                ", "#text": "(lxxv)"}, "@display-inline": "no-display-inline", "#text": "\n                ", "@id": "HB8A8E9667BFC4589AB54811B9263CE26", "@commented": "no"}, {"#tail": "\n              ", "text": {"#tail": "\n              ", "#text": "[3,2-c]pyrazole-5\u03b1-androstan-17\u03b2-ol; and"}, "enum": {"#tail": "\n                ", "#text": "(lxxvi)"}, "@id": "H6F41CBDD423E47718D1D2781DF1102DE", "#text": "\n                "}], "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t\t", "@id": "H8C29678092EF442DAB2F8EC744160029"}, "#text": "\n            ", "@id": "H639E3F06D8A6432496D16CEE34786EBB"}]}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "#text": "by adding at the end the following:"}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@id": "H94E4061704874B4C8C39DB119F1F8B94", "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "subparagraph": {"#tail": "\n            ", "clause": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": "\n                    \n                   and the limitations under ", "@entity-type": "act", "#text": "clause (ii)", "@value": "Controlled Substances Act/s:102/p:41/sp:C/cl:ii", "@proposed": "true"}, {"#tail": ", a drug or hormonal substance\n\t\t\t (other than estrogens, progestins, corticosteroids, and\n\t\t\t de\u00adhy\u00addro\u00adepi\u00adan\u00addros\u00adter\u00adone) that is not listed in ", "@entity-type": "act", "#text": "section 201(i)(6)", "@value": "Controlled Substances Act/s:201/ss:i", "@proposed": "true"}, {"#tail": " and\n\t\t\t is\n\t\t\t derived from, or has a chemical structure substantially similar to, 1 or\n\t\t\t more anabolic steroids listed in ", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Controlled Substances Act/s:102/p:41/sp:A"}, {"#tail": " shall be considered to\n\t\t\t be an anabolic steroid for purposes of this Act if\u2014", "@entity-type": "act", "#text": "subparagraph (A)", "@value": "Controlled Substances Act/s:102/p:41/sp:A"}], "#text": "Subject to \n                    \n                      "}, "enum": {"#tail": "\n                ", "#text": "(i)"}, "subclause": [{"@indent": "up1", "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "the drug or substance has been created or manufactured with the intent of producing a drug or other\n\t\t\t substance that either\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "promotes muscle growth; or"}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@id": "H895092599E9347C9A2129EE634C182A7", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "otherwise causes a pharmacological effect similar to that of testosterone; or"}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "@id": "H3C77FA4906DF485B9887F467F7FFEED1", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H0D1E14FCB8D24AD9BB84BFDD14E03C05"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "the drug or substance has been, or is intended to be, marketed or otherwise promoted in any manner\n\t\t\t suggesting that consuming it will promote muscle growth or any other\n\t\t\t pharmacological effect similar to that of testosterone."}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "#text": "\n                  ", "@id": "H953135ED23C54EB090308CC4E132528E"}], "@display-inline": "yes-display-inline", "#text": "\n                ", "@id": "H0D680D46D78B4CA2A266E1A4EA870485", "@commented": "no"}, {"@indent": "up1", "#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "A substance shall not be considered to be a drug or hormonal substance for purposes of this\n\t\t\t subparagraph if it\u2014"}, "enum": {"#tail": "\n                ", "#text": "(ii)"}, "subclause": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "is\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(I)"}, "item": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "an herb or other botanical;"}, "enum": {"#tail": "\n                    ", "#text": "(aa)"}, "@id": "H259D03473808494BB655CCD9F0B85343", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "a concentrate, metabolite, or extract of, or a constituent isolated directly from, an herb or other\n\t\t\t botanical; or"}, "enum": {"#tail": "\n                    ", "#text": "(bb)"}, "@id": "H1C94F539A86742B5BB823E05B4671BD7", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or ", "@entity-type": "act", "#text": "item (aa)", "@value": "Controlled Substances Act/s:102/p:41/sp:C/cl:ii/scl:I/i:aa", "@proposed": "true"}, {"#tail": "; and", "@entity-type": "act", "#text": "(bb)", "@value": "Controlled Substances Act/s:102/p:41/sp:C/cl:ii/scl:I/i:bb", "@proposed": "true"}], "#text": "a combination of 2 or more substances described in "}, "enum": {"#tail": "\n                    ", "#text": "(cc)"}, "@id": "H2D877B001303461AAB72FA78D7C166D3", "#text": "\n                    "}], "#text": "\n                  ", "@id": "H9962F665611A49468C26C25FFD1A38B1"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "is a dietary ingredient for purposes of the ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": ".", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " (", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}, {"#tail": ")", "@entity-type": "uscode", "#text": "21 U.S.C. 301 et\n\t\t\t seq.", "@value": "usc/21/301/etseq"}], "@entity-type": "law-citation", "#text": "\n                      "}}, "enum": {"#tail": "\n                  ", "#text": "(II)"}, "@id": "H37DE8FF9E95A4ED49F37D7B56ABA94AE", "#text": "\n                  "}], "#text": "\n                ", "@id": "H48F7233ED6484782A2BC3DA35D46A35E"}, {"@indent": "up1", "#tail": "\n            ", "text": {"#tail": "\n              ", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", any person claiming the benefit of an exemption or exception\n\t\t\t under ", "@entity-type": "act", "#text": "section 515(a)", "@value": "Controlled Substances Act/s:515/ss:a"}, {"#tail": " shall bear the burden of going forward with the evidence\n\t\t\t with respect to such exemption or exception.", "@entity-type": "act", "#text": "clause (ii)", "@value": "Controlled Substances Act/s:102/p:41/sp:C/cl:ii", "@proposed": "true"}], "#text": "In accordance with "}, "enum": {"#tail": "\n                ", "#text": "(iii)"}, "#text": "\n                ", "@id": "HEB3A67A3D3A54214B881D93AC62B6CB7"}], "enum": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "(C)"}, "@id": "H53CB0A7F5EFB40CBBEA9EAFDE3999D85", "#text": "\n              "}}, "#text": "\n          ", "@id": "HA8091FB974E248AC83A7D35F893157EE"}], "#text": "\n        ", "@id": "H83BB015182A8468784C6CBDAA0C94F4C"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t", "#text": "\n          ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " is amended by adding at the end the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "Section 201 of the Controlled Substances Act", "@value": "Controlled Substances Act/s:201"}, "@entity-type": "law-citation", "#text": "\n            ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n          ", "@entity-type": "uscode", "#text": "21 U.S.C. 811", "@value": "usc/21/811"}, "@parsable-cite": "usc/21/811", "#text": "\n            ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n        ", "#text": "(b)"}, "header": {"#tail": "\n        ", "#text": "Classification authority"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n        ", "#text": "."}, "#tail": "\n\t\t\t", "subsection": {"#tail": "\n          ", "enum": {"#tail": "\n            ", "#text": "(i)"}, "header": {"#tail": "\n\t\t\t\t\t\t", "#text": "Temporary and permanent scheduling of recently emerged anabolic steroids"}, "paragraph": [{"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may issue a temporary order adding a drug or other substance to the list of\n\t\t\t anabolic steroids if the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " finds that\u2014", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "The "}, "enum": {"#tail": "\n              ", "#text": "(1)"}, "#text": "\n              ", "@id": "H826092DFAB0A496DA59045E1D3B0B885", "subparagraph": [{"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " but is not listed in that section or by regulation of the\n\t\t\t ", "@entity-type": "act", "#text": "section 102(41)", "@value": "Controlled Substances Act/s:102/ss:41"}, {"#tail": " as being an anabolic steroid; and", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}], "#text": "the drug or other substance satisfies the criteria for being considered an anabolic steroid under\n\t\t\t "}, "enum": {"#tail": "\n                ", "#text": "(A)"}, "@id": "H5259BFC6DB504B52A33FA51536864BF7", "#text": "\n                "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "adding such drug or other substance to the list of anabolic steroids will assist in preventing the\n\t\t\t unlawful importation, manufacture, distribution, or dispensing of such\n\t\t\t drug or other substance."}, "enum": {"#tail": "\n                ", "#text": "(B)"}, "@id": "H3BA0DF4790E34097BA33DC26FD793168", "#text": "\n                "}]}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall not take effect until 30 days after the date of the\n\t\t\t publication by the ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:201/ss:i/p:1", "@proposed": "true"}, {"#tail": " of a notice in the Federal Register of\n\t\t\t the intention to issue such order and the grounds upon which such order is\n\t\t\t to be issued. The order shall expire not later than 24 months after the\n\t\t\t date it becomes effective, except that the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " may, during\n\t\t\t the pendency of proceedings under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ", extend the temporary\n\t\t\t scheduling order for up to 6 months.", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Controlled Substances Act/s:201/ss:i/p:5", "@proposed": "true"}], "#text": "An order issued under "}, "enum": {"#tail": "\n              ", "#text": "(2)"}, "@id": "HB053562666F94B5CB20FF06B12A2C300", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " shall be vacated upon the issuance of a\n\t\t\t permanent scheduling order under ", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:201/ss:i/p:1", "@proposed": "true"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (5)", "@value": "Controlled Substances Act/s:201/ss:i/p:5", "@proposed": "true"}], "#text": "A temporary scheduling order issued under "}, "enum": {"#tail": "\n              ", "#text": "(3)"}, "@id": "HD7F59193ACC4478C96849D24DE19C991", "#text": "\n              "}, {"#tail": "\n            ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is not subject to judicial review.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:201/ss:i/p:1", "@proposed": "true"}, "#text": "An order issued under "}, "enum": {"#tail": "\n              ", "#text": "(4)"}, "@id": "HFB8710BB6241475D980B47DB8F665886", "#text": "\n              "}, {"#tail": "\n          ", "text": {"#tail": "\n\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, by rule, issue a permanent order adding a drug or other substance to the\n\t\t\t list of anabolic steroids if such drug or other substance satisfies the\n\t\t\t criteria for being considered an anabolic steroid under ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": ".\n\t\t\t Such rulemaking may be commenced simultaneously with the issuance of the\n\t\t\t temporary order issued under ", "@entity-type": "act", "#text": "section 102(41)", "@value": "Controlled Substances Act/s:102/ss:41"}, {"#tail": ".", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:201/ss:i/p:1", "@proposed": "true"}], "#text": "The ", "@display-inline": "yes-display-inline"}, "enum": {"#tail": "\n              ", "#text": "(5)"}, "@id": "H87AB401144F846CEA156B4181F0C6403", "#text": "\n              "}], "#text": "\n            ", "@id": "H778BCCE7409B4DE192895ADB08FA61B1"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t", "@id": "H866DE47E6DFC4485B194A435D09137C2"}, "#text": "\n        ", "@id": "H7BB301ECB28D4F98A707AECFE25B7792"}, {"#tail": "\n    ", "enum": {"#tail": "\n        ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t", "#text": "Labeling requirements"}, "paragraph": [{"#tail": "\n        ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " is amended by inserting after ", "@entity-type": "act", "#text": "Controlled Substances Act", "@value": "Controlled Substances Act"}, "#text": "The ", "{http://namespaces.cato.org/catoxml}entity": {"#tail": " the\n\t\t\t following:", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " (", "@entity-type": "act", "#text": "section 305", "@value": "Controlled Substances Act/s:305"}, "@entity-type": "law-citation", "#text": "\n              ", "external-xref": {"#tail": ")", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n            ", "@entity-type": "uscode", "#text": "21 U.S.C. 825", "@value": "usc/21/825"}, "@parsable-cite": "usc/21/825", "#text": "\n              ", "@legal-doc": "usc"}}}, "enum": {"#tail": "\n          ", "#text": "(1)"}, "header": {"#tail": "\n          ", "#text": "In general"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "section": {"#tail": "\n            ", "enum": {"#tail": "\n              ", "#text": "305A."}, "header": {"#tail": "\n\t\t\t\t\t\t\t", "#text": "Offenses involving false labeling of anabolic steroids"}, "subsection": [{"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(a)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Unlawful acts"}, "paragraph": [{"continuation-text": {"#tail": "\n                ", "@continuation-text-level": "paragraph", "#text": "any anabolic steroid, or any product containing an anabolic steroid, unless it bears a label\n\t\t\t clearly identifying any anabolic steroid contained in such steroid or\n\t\t\t product by the nomenclature used by the International Union of Pure and\n\t\t\t Applied Chemistry (IUPAC)."}, "#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "It shall be unlawful\u2014"}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "#text": "\n                  ", "@id": "H1269834B5DF44BB7B5C737F5AD41AE56", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "to import into the United States or to export from the United States;"}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "H4101A53E601E4A9B854755067D53C6A5", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "#text": "to manufacture, distribute, dispense, sell, or offer to sell; or"}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "HDDC0EA37DE264A27B66BB3B5BD2F813B", "#text": "\n                    "}, {"#tail": "\n                  ", "text": {"#tail": "\n                  ", "#text": "to possess with intent to manufacture, distribute, dispense, sell, or offer to sell;"}, "enum": {"#tail": "\n                    ", "#text": "(C)"}, "@id": "H9B0436602B714E4BBCE1E732B51E6951", "#text": "\n                    "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": ", ", "@entity-type": "act", "#text": "section 505(b)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:b"}, {"#tail": " or ", "@entity-type": "act", "#text": "(i)", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:i"}, {"#tail": " (\n                    ", "@entity-type": "act", "#text": "(j)\n\t\t\t of the Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act/s:505/ss:j"}, {"#tail": ", or\n\t\t\t ", "@entity-type": "uscode", "#text": "(i)", "@value": "usc/21/355/i"}, {"#tail": ") is exempt from the International Union of Pure and Applied Chemistry\n\t\t\t nomenclature requirement of this subsection if such product is labeled in\n\t\t\t the manner required by the ", "@entity-type": "uscode", "#text": "(j)", "@value": "usc/21/355/j"}, {"#tail": ".", "@entity-type": "act", "#text": "Federal Food, Drug, and Cosmetic Act", "@value": "Federal Food, Drug, and Cosmetic Act"}], "#text": "A product that is the subject of an approved application as described in ", "external-xref": {"#tail": ", ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                    ", "@entity-type": "uscode", "#text": "21 U.S.C. 355(b)", "@value": "usc/21/355/b"}, "@parsable-cite": "usc/21/355", "#text": "\n                      ", "@legal-doc": "usc"}}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "H225C2384C5194F2ABCC1A64F9DD24BA6", "#text": "\n                  "}], "#text": "\n                ", "@id": "H5BBB0647F1FF425DAE0540735C754DCE"}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " knowing, intending, or having reasonable cause to believe,\n\t\t\t that the substance or product is an anabolic steroid, or contains an\n\t\t\t anabolic steroid, shall be sentenced to a term of imprisonment of not more\n\t\t\t than 10 years, a fine not to exceed the greater of that authorized in\n\t\t\t accordance with the provisions of ", "@entity-type": "act", "#text": "subsection (a)", "@value": "Controlled Substances Act/s:305A/ss:a", "@proposed": "true"}, {"#tail": ", or\n\t\t\t $500,000 if the defendant is an individual or $2,500,000 if the defendant\n\t\t\t is other than an individual, or both.", "@entity-type": "uscode", "#text": "title 18, United States Code", "@value": "usc/18"}], "#text": "Any person who violates "}, "enum": {"#tail": "\n                ", "#text": "(b)"}, "header": {"#tail": "\n                ", "#text": "Criminal penalties"}, "#text": "\n                ", "@id": "H5C1BD3FC857E45959530C33345C6D778"}, {"#tail": "\n              ", "enum": {"#tail": "\n                ", "#text": "(c)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Civil penalties"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall be subject to a civil penalty as follows:", "@entity-type": "act", "#text": "subsection (a)", "@value": "Controlled Substances Act/s:305A/ss:a", "@proposed": "true"}, "#text": "Any person who violates "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "#text": "\n                  ", "@id": "H89BFC0A8894F4B3391276EF71084BECE", "subparagraph": [{"#tail": "\n                  ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": "\n                      ), up to $500,000 per violation. For purposes of this\n\t\t\t subparagraph, a violation is defined as each instance of importation,\n\t\t\t exportation, manufacturing, or distribution, and each anabolic steroid or\n\t\t\t product imported, exported, manufactured, or distributed.", "@entity-type": "act", "#text": "subparagraph (B)", "@value": "Controlled Substances Act/s:305A/ss:c/p:1/sp:B", "@proposed": "true"}, "#text": "In the case of an importer, exporter, manufacturer, or distributor (other than as provided in\n\t\t\t \n                        "}, "enum": {"#tail": "\n                    ", "#text": "(A)"}, "@id": "H48B04E6C8FA24653B6710011849C4C35", "#text": "\n                    "}, {"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " or the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " shall be considered\n\t\t\t additional violations.", "@entity-type": "federal-body", "#text": "Secretary", "@entity-id": "7500"}], "#text": "In the case of a sale or offer to sell at retail, up to $25,000 per violation. For purposes of this\n\t\t\t subparagraph, each sale and each product offered for sale shall be\n\t\t\t considered a separate violation. Continued offers to sell by a person 10\n\t\t\t or more days after written notice (including through electronic message)\n\t\t\t to the person by the "}, "enum": {"#tail": "\n                    ", "#text": "(B)"}, "@id": "H4A52FA2281A44EE5964AC513A0074FE4", "#text": "\n                    "}]}, {"#tail": "\n              ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "term": {"#tail": " means a discrete article, either in bulk or in finished form prepared for sale. A number of\n\t\t\t articles, if similarly packaged and bearing identical labels, shall be\n\t\t\t considered as one product, but each package size, form, or differently\n\t\t\t labeled article shall be considered a separate product.", "#text": "product"}, "#text": "In this subsection, the term "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "H0CFB05C5A76442C287AE93C825A2FB3E", "#text": "\n                  "}], "#text": "\n                ", "@id": "H16E195FA144448C4866893A370E43F01"}, {"#tail": "\n            ", "enum": {"#tail": "\n                ", "#text": "(d)"}, "header": {"#tail": "\n\t\t\t\t\t\t\t\t", "#text": "Identification and publication of list of products containing anabolic steroids"}, "paragraph": [{"#tail": "\n                ", "text": {"#tail": "\n\t\t\t\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " may, in his discretion, collect data and analyze products to determine whether\n\t\t\t they contain anabolic steroids and are properly labeled in accordance with\n\t\t\t this section. The ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " may publish in the Federal Register or\n\t\t\t on the website of the ", "@entity-type": "federal-body", "#text": "Attorney General", "@entity-id": "1500"}, {"#tail": " a list of products\n\t\t\t that he has determined, based on substantial evidence, contain an anabolic\n\t\t\t steroid and are not labeled in accordance with this section.", "@entity-type": "federal-body", "#text": "Drug Enforcement Administration", "@entity-id": "1524"}], "#text": "The "}, "enum": {"#tail": "\n                  ", "#text": "(1)"}, "@id": "H5BCA138E5C634EDAA0DCE548B271A231", "#text": "\n                  "}, {"#tail": "\n              ", "text": {"#tail": "\n                ", "{http://namespaces.cato.org/catoxml}entity-ref": {"#tail": " shall not constitute evidence\n\t\t\t that the product does not contain an anabolic steroid.", "@entity-type": "act", "#text": "paragraph (1)", "@value": "Controlled Substances Act/s:305A/ss:d/p:1", "@proposed": "true"}, "#text": "The absence of a product from the list referred to in "}, "enum": {"#tail": "\n                  ", "#text": "(2)"}, "@id": "H6527712D68D14EEF98668A970FACB43A", "#text": "\n                  "}], "#text": "\n                ", "@id": "H8EA38AFF3B824385A1767ADA2DA361F0"}], "#text": "\n              ", "@id": "HA3115697295D4B80BCA8F0B9F1A44777"}, "@display-inline": "no-display-inline", "#text": "\n\t\t\t\t\t\t", "@id": "H8A9CE8CCFD2F4CF289CCC8A482C7CF36"}, "#text": "\n          ", "@id": "H9F4C9C5CEBAC49CDADD8036E69B9FBEA"}, {"#tail": "\n      ", "text": {"#tail": "\n\t\t\t\t\t", "{http://namespaces.cato.org/catoxml}entity-ref": [{"#tail": " is\n\t\t\t amended by inserting after the item relating to ", "@entity-type": "act", "#text": "Comprehensive Drug Abuse Prevention and Control Act of 1970", "@value": "Comprehensive Drug Abuse Prevention and Control Act of 1970"}, {"#tail": " the following:", "@entity-type": "act", "#text": "section 305", "@value": "Comprehensive Drug Abuse Prevention and Control Act of 1970/s:305"}], "#text": "The table of contents for the "}, "enum": {"#tail": "\n          ", "#text": "(2)"}, "header": {"#tail": "\n          ", "#text": "Table of contents"}, "quoted-block": {"@style": "OLC", "after-quoted-block": {"#tail": "\n          ", "#text": "."}, "#tail": "\n\t\t\t\t", "@display-inline": "no-display-inline", "toc": {"#tail": "\n            ", "#text": "\n\t\t\t\t\t\t\t", "toc-entry": {"#tail": "\n            ", "@level": "section", "#text": "Sec. 305A. Offenses involving false labeling of anabolic steroids.", "@bold": "off"}}, "#text": "\n\t\t\t\t\t\t", "@id": "H2D5F15007B86495AA05A4EA599920A45"}, "#text": "\n          ", "@id": "H2BF28F2F03E54AF682A645BFEC639C71"}], "#text": "\n        ", "@id": "H82670C0FCA99463E96ACDAA18CD8EC43"}], "#text": "\n      ", "@id": "H27BF813D8C1C401DB0237C1439EA75D9"}], "#text": "\n\t\t", "@id": "H550032FEDE93424A83A73D320B86FB01"}, "metadata": {"#tail": "\n", "dublinCore": {"{http://purl.org/dc/elements/1.1/}date": {"#tail": "\n", "#text": "2014-05-29"}, "{http://purl.org/dc/elements/1.1/}format": {"#tail": "\n", "#text": "text/xml"}, "{http://purl.org/dc/elements/1.1/}language": {"#tail": "\n", "#text": "EN"}, "#tail": "\n", "{http://purl.org/dc/elements/1.1/}title": {"#tail": "\n", "#text": "113 HR 4771 IH: Designer Anabolic Steroid Control Act of 2014"}, "{http://purl.org/dc/elements/1.1/}rights": {"#tail": "\n", "#text": "Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain."}, "{http://purl.org/dc/elements/1.1/}publisher": {"#tail": "\n", "#text": "U.S. House of Representatives"}, "#text": "\n"}, "#text": "\n"}}}